Lynparza 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F48AB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,247
Award facts
- Contract value 100% obligated
- $12,246.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,246.61 to AmerisourceBergen Drug Corp for the supply of Lynparza (olaparib) 100 mg tablets in a quantity of 120 units. The award, issued on February 4, 2026, with an ultimate completion date of February 26, 2026, represents a firm fixed-price contract with no set-aside designation, indicating competitive award through open competition. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, a single-award vehicle valued at $999,999,999.00 through December 31, 2031, which serves as the primary mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Lynparza is an oncology medication used in cancer treatment, consistent with AmerisourceBergen's established role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The company supplies a comprehensive range of therapeutic products including specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple disease states. The performance location in Conshohocken, Pennsylvania reflects AmerisourceBergen's corporate headquarters location, underscoring the company's operational capacity to fulfill federal pharmaceutical procurement requirements for the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26F48AB?
SPE2DR26F48AB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F48AB worth?
The government has obligated $12,247 on SPE2DR26F48AB.
Is contract SPE2DR26F48AB an order under another contract?
Yes. SPE2DR26F48AB is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F48AB competed?
The extent of competition for SPE2DR26F48AB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award